Drugs / MECOBALAMIN
MECOBALAMIN
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT03968042 Background | Jun 2019 → Dec 2021 | brain injury | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | Unknown | Mixed |
Evidence & citations 6 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | MECOBALAMIN | ChEMBL registry synonym — accepted as the source's own label CHEMBL2359370 ↗ |
| Known as | Asimil b-12 | ChEMBL registry synonym — accepted as the source's own label CHEMBL2359370 ↗ |
| Known as | B-max | ChEMBL registry synonym — accepted as the source's own label CHEMBL2359370 ↗ |
| Known as | Mecobalamina | ChEMBL registry synonym — accepted as the source's own label CHEMBL2359370 ↗ |
| Known as | mecobalamine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03968042 ↗ |
| Modality | Small molecule | — CHEMBL2359370 ↗ |